Umicore supports pediatric oncology at German Würzburg's university clinic

Regional website Germany

Umicore’s business unit Precious Metals Chemistry donates € 5.000 to a parents initiative for children suffering from leukemia and other cancer diseases in order to support important R&D projects in the area of pediatric oncology at Würzburg’s university clinic.

Combating cancer, especially when children are affected, is an important concern to Umicore’s business unit Precious Metals Chemistry (PMC). Therefore, the materials technology company does not only develop and produce products for cancer treatment, but also helps directly. The pediatric oncology Würzburg is supported with a donation of € 5.000 to a parents initiative for children suffering from leukemia and other cancer diseases. This in Germany one-of-a-kind medical center is also engaged in difficult areas such as stem cell transplantation and brain tumours.

Michael Schwarz, Director Global API Business, explains: "The pediatric oncology at Würzburg’s university clinic is unique in Germany thanks to its outstanding achievements for children and adolescents suffering from cancer. Since we are working on products for cancer treatment for many years now, we wanted to help on the spot with a donation."

The university pediatric clinic takes care of approximately 90 to 100 children and adolescents each year, who have been diagnosed with malignancy. They are taken care of ambulatory and as an inpatient. Umicore’s donation supports important projects in the area of pediatric oncology, such as the development of new therapeutic approaches, for instance a tumour vaccination or the creation of tumour specific immune cells. Thereby scientists in Würzburg want to achieve that children and adolescents who cannot be entirely cured today, will receive the chance to full recovery in the future.

"We are very grateful for Umicore’s support. The donation will directly benefit both the improvement of prognosis for critically ill children and adolescents and their families", commented professor doctor Paul Schlegel, head of centre for paediatric haematology, oncology and stem cell transplantation.

Platinum based compounds were recognized as chemotherapeutic in the 1970’s. Since then, these products continue to play an instrumental role in cancer treatment. Umicore’s PMC business unit produces oxaliplatin carboplatin and cisplatin, so called active pharmaceutical ingredients (APIs). With over 40 years of experience in precious metal chemistry and over a decade of platinum API experience, Umicore globally contributes to cancer treatment.

Umicore Precious Metals Chemistry profile

Umicore Precious Metals Chemistry strengths are a combination of customer orientation, expertise in transition metals chemistry, Precious Metal based APIs, catalysts and chemicals manufacturing and process excellence, innovation leadership and diversity. Focused on answering accurately to its customer needs, it works in technology platforms aligning all necessary resources from Research & Development to Marketing & Sales through Production & Technology on a worldwide basis. It offers first class products and services allowing customers to use metal based technologies in the most effective and sustainable way.

Our website: 


      Umicore uses certain monitoring and tracking technologies such as cookies. These technologies are used in order to maintain, provide and improve our services on an ongoing basis, and in order to provide our web visitors with a better experience.

      By clicking on the "Accept all" button you agree to the use of these cookies while using the website. For further information regarding how we use cookies and other tracking technologies, please see section 11 of our website privacy notice

          Necessary cookies are essential and help you navigate our website. This helps to support security and basic functionality and are necessary for the proper operation of our website, so if you block these cookies we cannot guarantee your use or the security during your visit.

          Cookies that help us to understand the behaviour of users of our website. This allows us to continuously improve our website to provide the best information in support of our project aims. These cookies also help us understand the effectiveness of our website. For instance these cookies tell us which pages visitors go to most often and if they get error messages from web pages.

          Cookies that deliver content to you based on your interests, which are assumed from your browsing history. Most Targeting Cookies track users via their IP address and, thus, may collect some Personal Data. Personal Data collected by Targeting Cookies may be shared with third parties, such as advertisers.